85 related articles for article (PubMed ID: 13715666)
21. Kinetics of serum and local cytokine profile in experimental intravaginal trichomoniasis induced with Trichomonas vaginalis isolates from symptomatic and asymptomatic women.
Malla N; Yadav M; Gupta I
Parasite Immunol; 2007 Feb; 29(2):101-5. PubMed ID: 17241398
[TBL] [Abstract][Full Text] [Related]
22. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon.
Garcia A; Exposto F; Prieto E; Lopes M; Duarte A; Correia da Silva R
Int J STD AIDS; 2004 Sep; 15(9):615-8. PubMed ID: 15339370
[TBL] [Abstract][Full Text] [Related]
23. Characterization of nucleoside triphosphate diphosphohydrolase activity in Trichomonas gallinae and the influence of penicillin and streptomycin in extracellular nucleotide hydrolysis.
Borges FP; de Brum Vieira P; Wiltuschnig RC; Tasca T; De Carli GA; Bonan CD
FEMS Microbiol Lett; 2008 Jun; 283(2):189-95. PubMed ID: 18422631
[TBL] [Abstract][Full Text] [Related]
24. A divergent ADP/ATP carrier in the hydrogenosomes of Trichomonas gallinae argues for an independent origin of these organelles.
Tjaden J; Haferkamp I; Boxma B; Tielens AG; Huynen M; Hackstein JH
Mol Microbiol; 2004 Mar; 51(5):1439-46. PubMed ID: 14982636
[TBL] [Abstract][Full Text] [Related]
25. [Preparation of monoclonal antibodies against the adhesion protein 33 of Trichomonas vaginalis].
Huang HC; Yu SF; Cai M; Tan F; Zheng XY; Pan CW
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Apr; 25(2):97-100, 105. PubMed ID: 17633817
[TBL] [Abstract][Full Text] [Related]
26. Trichomonas vaginalis: in vitro survival in swimming pool water samples.
Pereira-Neves A; Benchimol M
Exp Parasitol; 2008 Mar; 118(3):438-41. PubMed ID: 17949719
[TBL] [Abstract][Full Text] [Related]
27. A quantitative resazurin assay to determinate the viability of Trichomonas vaginalis and the cytotoxicity of organic solvents and surfactant agents.
Duarte M; Giordani RB; De Carli GA; Zuanazzi JA; Macedo AJ; Tasca T
Exp Parasitol; 2009 Oct; 123(2):195-8. PubMed ID: 19619538
[TBL] [Abstract][Full Text] [Related]
28. Intranasal immunisation with a 62 kDa proteinase combined with cholera toxin or CpG adjuvant protects against Trichomonas vaginalis genital tract infections in mice.
Hernández HM; Figueredo M; Garrido N; Sánchez L; Sarracent J
Int J Parasitol; 2005 Nov; 35(13):1333-7. PubMed ID: 16202417
[TBL] [Abstract][Full Text] [Related]
29. Trichomonas vaginalis infection in male sexual partners: implications for diagnosis, treatment, and prevention.
Seña AC; Miller WC; Hobbs MM; Schwebke JR; Leone PA; Swygard H; Atashili J; Cohen MS
Clin Infect Dis; 2007 Jan; 44(1):13-22. PubMed ID: 17143809
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.
Helms DJ; Mosure DJ; Metcalf CA; Douglas JM; Malotte CK; Paul SM; Peterman TA
Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314
[TBL] [Abstract][Full Text] [Related]
31. Surface properties and in vitro cytopathic effect of various strains of Trichomonas vaginalis.
González-Robles A; Espinosa-Cantellano M; Argüello C; Anaya-Velázquez F; Lázaro-Haller A; Martínez-Palomo A
J Submicrosc Cytol Pathol; 2004 Jan; 36(1):77-83. PubMed ID: 15311677
[TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies against a 62 kDa proteinase of Trichomonas vaginalis decrease parasite cytoadherence to epithelial cells and confer protection in mice.
Hernández H; Sariego I; Garber G; Delgado R; López O; Sarracent J
Parasite Immunol; 2004 Mar; 26(3):119-25. PubMed ID: 15279622
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of affirm VPIII in the detection and identification of Trichomonas vaginalis, Gardnerella vaginalis, and Candida species in vaginitis/vaginosis.
Brown HL; Fuller DD; Jasper LT; Davis TE; Wright JD
Infect Dis Obstet Gynecol; 2004; 12(1):17-21. PubMed ID: 15460191
[TBL] [Abstract][Full Text] [Related]
34. [In vitro sensitivity of Trichomonas gallinae and Trichomonas fetus to neomycine and viomycin].
DEOM J; MORTELMANS J
Ann Inst Pasteur (Paris); 1955 Apr; 88(4):521-2. PubMed ID: 13403315
[No Abstract] [Full Text] [Related]
35. Analysis of microtubule cytoskeleton distribution using a fluorescent taxoid in two trichomonadid protozoa: Trichomonas gallinae and Tritrichomonas foetus.
Vieira PB; Borges FP; Gottardi B; Stuepp C; Larré AB; Tasca T; De Carli GA
Exp Parasitol; 2008 May; 119(1):186-91. PubMed ID: 18255064
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of immunoglobulin G, M, A and IgG subclass responses in experimental intravaginal trichomoniasis: prominence of IgG1 response.
Yadav M; Gupta I; Malla N
Parasite Immunol; 2005 Dec; 27(12):461-7. PubMed ID: 16255745
[TBL] [Abstract][Full Text] [Related]
37. Alternative drugs against Trichomonas vaginalis.
Mahdi NK; Gany ZH; Sharief M
East Mediterr Health J; 2006 Sep; 12(5):679-84. PubMed ID: 17333809
[TBL] [Abstract][Full Text] [Related]
38. [Quantitative determination of the hyaluronidase activity of Trichomonas vaginalis].
FILADORO F; ORSI N
Nuovi Ann Ig Microbiol; 1960; 11():598-601. PubMed ID: 13699440
[No Abstract] [Full Text] [Related]
39. Apoptosis of macrophages induced by Trichomonas vaginalis through the phosphorylation of p38 mitogen-activated protein kinase that locates at downstream of mitochondria-dependent caspase activation.
Chang JH; Kim SK; Choi IH; Lee SK; Morio T; Chang EJ
Int J Biochem Cell Biol; 2006; 38(4):638-47. PubMed ID: 16360334
[TBL] [Abstract][Full Text] [Related]
40. Trichomonas vaginalis-induced apoptosis in RAW264.7 cells is regulated through Bcl-xL, but not Bcl-2.
Chang JH; Ryang YS; Kim SK; Park JY
Parasite Immunol; 2004 Mar; 26(3):141-50. PubMed ID: 15279625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
